Haifeng Lu
- Hepatology top 2%
- Liver Disease and Transplantation 8
- Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research 14
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 13
- Hepatitis B Virus Studies 8
- Biological Psychiatry top 5%
- Molecular Biology top 5%
- Gut microbiota and health 32
-
- Probiotics and Fermented Foods 7
-
- Diet and metabolism studies 5
-
- Antibiotic Resistance in Bacteria 5
- Journals
- Microbial Ecology (5 papers)Scientific Reports (4 papers)Frontiers in Microbiology (3 papers)
- Partner nations
- ChinaMadagascarNetherlands
In The Last Decade
Haifeng Lu
61 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Hepatology 517
- Infectious Diseases 795
- Epidemiology 1.4k
- Biological Psychiatry 93
- Molecular Biology 2.5k
Countries citing papers authored by Haifeng Lu
This map shows the geographic impact of Haifeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Lu more than expected).
Fields of papers citing papers by Haifeng Lu
This network shows the impact of papers produced by Haifeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Lu. The network helps show where Haifeng Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haifeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders | 2022 | 7 |
| 5 | 2021 | 20 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 5 | |
| 8 | 2019 | 103 | |
| 9 | 2019 | 21 | |
| 10 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinomabreakdown → | 2018 | 543 |
| 11 | 2017 | 11 | |
| 12 | 2017 | 20 | |
| 13 | 2014 | 25 | |
| 14 | 2014 | 77 | |
| 15 | 2013 | 65 | |
| 16 | 2012 | 42 | |
| 17 | 2011 | 178 | |
| 18 | 2011 | 14 | |
| 19 | Characterization of fecal microbial communities in patients with liver cirrhosisbreakdown → | 2011 | 801 |
| 20 | ERIC-PCR based fingerprinting and molecular hybridization to analyze the characteristics of intestinal microflora of giant panda | 2005 | 3 |
About Haifeng Lu
Haifeng Lu is a scholar working on Hepatology, Molecular Medicine and Infectious Diseases, having authored 62 papers that have together received 3.8k indexed citations. Recurring topics across this work include Gut microbiota and health (32 papers), Clostridium difficile and Clostridium perfringens research (14 papers), Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (8 papers), Hepatitis B Virus Studies (8 papers), Probiotics and Fermented Foods (7 papers), Diet and metabolism studies (5 papers) and Antibiotic Resistance in Bacteria (5 papers). The work is most often cited by research in Hepatology (517 citations), Infectious Diseases (795 citations) and Epidemiology (1.4k citations). Haifeng Lu has collaborated with scholars based in China, Madagascar and Netherlands. Frequent co-authors include Lanjuan Li, Yunbo Chen, Yanfei Chen, Shusen Zheng, Zhigang Ren, Fengling Yang, Baohong Wang, Baoli Zhu, Yuezhu Wang and Dajiang Lei. Their work appears in journals such as Microbial Ecology, Scientific Reports, Frontiers in Microbiology, Frontiers in Cellular and Infection Microbiology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.